Close Menu

In Newsweek, George Church writes that the message that people get from knowing their genomes "is not 'Here's your destiny. Get used to it!' Instead, it's 'Here's your destiny, and you can do something about it!'" Though pharmacogenomics is in its early days, Church points out that it is already being used to help patients. Furthermore, he adds that cheaper genomics will not only change the course of biological research, but also bestow benefits upon the public as a whole.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.